420 with CNW – 4 Roadblocks in the Way of Marijuana Franchises

Franchising is one of the giant economic forces in the U.S. given the fact that this business model generated approximately $451 billion in 2018. Are we about to see cannabis enterprises built upon this model? Anyone intending to enter cannabis franchising needs to think about and find remedies to the following major bottlenecks.

Conflicts Between State and Federal Laws

Despite the legalization of marijuana for recreational or medical use in various states across the U.S., cannabis remains a Schedule 1 substance at the federal level. This creates major legal issues for businesses which wish to operate franchises in the cannabis industry. For example, a franchise owner cannot ship products across state lines in order to sell the excess products from one state in another state where supply is limited. This makes the possibility of prices nose-diving a real concern since gluts inevitably result in plummeting prices.

Tax Issues

According to the federal tax code, marijuana businesses aren’t eligible for any deductibles on the costs that they incur during the execution of their business activities. For example, marijuana businesses cannot deduct the cost of buying business premises and yet other enterprises which don’t transact in Schedule 1 substances can claim tax deductions on this business expense. These tax disadvantages mean that cannabis businesses will struggle to be profitable unless they can find ways to be super-efficient regarding non-deductible expenses.

Limited Consumer Awareness

Marijuana has been prohibited for long and certain stereotypes about the substance still exist even where prohibition has ended. Cannabis franchisees would therefore have to do a lot to educate their prospective customers in order to make sales on a consistent basis. This added challenge of performing customer education on an ongoing basis isn’t faced by franchises in other industries, such as the fast foods industry.

Limited Investor Interest

Currently, investors aren’t too eager to put their money in an industry which still faces legal uncertainties. This explains why US-based marijuana companies are generally undervalued when compared to their Canadian-based counterparts, for example. While this limited investor appeal exists, any cannabis franchisers that set up shop may struggle to attract investors unless the legal space changes for the better.

In the true entrepreneurial spirit, every challenge presents a business opportunity. The cannabis franchise space is therefore open for the taking for those individuals who devise ways to bring a franchise concept into the cannabis space in a way that ensures that investors will earn a return despite the challenges above. Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) hope that enterprising individuals will take up this challenge and devise franchises which will spur the growth of the cannabis industry even more.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Physician Shortage May Cause Australian Medical Cannabis Program to Fail

While medical marijuana is legal in Australia, many patients are finding it difficult to find physicians who are willing to prescribe the substance. This has forced those patients to resort to illicit sources of medical marijuana in order to alleviate their symptoms.

Qualifying patients, such as Trembath Forster who lives in Canberra, say that they have to travel hundreds of miles to access a doctor who is licensed and willing to prescribe medical marijuana. Such trips are not only financially strenuous but also nearly impossible for patients with mobility challenges.

Trembath Forster reveals that she and other patients have encountered ignorance and outright arrogance when they approached many local doctors about a prescription for medical marijuana. Such doctors have no qualms about putting the patients on any strong opioids or prescription medications available, but they become hostile or evasive when the subject of medical cannabis is raised.

Australian law imposes stringent conditions which must be met before a patient can use medical marijuana. First, the patient must find a doctor who has been licensed to prescribe “unapproved therapeutic goods.”

For a physician to get such a license, he or she must have undergone extensive training and acquired expertise in the condition/disease from which the patient is suffering. The physician should also have undergone training on how to use the “unapproved therapeutic goods” to treat the specific condition for which the patient is seeking medical marijuana as a remedy.

The licensed physician is also expected to monitor the condition of the patient while that patient is using medical marijuana. In other words, the physician is responsible for what happens to the patient as a result of that patient’s consumption of medical marijuana.

Benjamin Graham, the Executive Director of a non-profit called Chronic Pain Australia, explains that those stringent conditions could be to blame for the brick wall patients run into when they talk to their GP about medical marijuana. In Trembath Forster’s case, her GP was sympathetic but lacked the license to prescribe medical marijuana.

Graham added that most patients his organization interacts with say that their GPs are either ignorant about medical marijuana or they are biased against the treatment option. He has hope that as more patients request for medical marijuana, more doctors will undergo the needed training in order to get the license from the Therapeutic Goods Administration of the Australian government’s Department of Health.

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) hope that the authorities in Australia come to the aid of the patients and conduct campaigns to register more physicians on the medical marijuana program. This will make it easier for the patients who desperately need medical marijuana to get a prescription for it.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Patients Still Face Challenges Accessing Medical Marijuana, Toronto Conference Attendees Reveal

One would imagine that once a country or jurisdiction legalizes medical cannabis, then the patients there will find it easy to access prescription medical cannabis products. Sadly, this isn’t the case as panelists and attendees of the Medical Cannabis Conference in Toronto last week revealed.

The first major challenge that medical cannabis patients face is the high prices of products. A clear example of this is in Canada which has had medical marijuana since 2001.

Gerald Major, who is the president of a medical cannabis advocacy group in Canada called Canadians for Fair Access to Medical Cannabis, revealed during the conference that the legalization of recreational marijuana in Canada has made matters worse for patients taking medical cannabis.

For example, the high taxes imposed on recreational marijuana have increased the cost of medical marijuana as well. Additionally, the supply shortages in the recreational segment have also reduced inventory for the medical cannabis retailers, and this has forced patients to underdose or go without medical cannabis for a while.

Furthermore, restrictions that didn’t exist earlier have now been imposed on medical marijuana users as well. For example, no exceptions for medical cannabis patients have been made in the rules governing driving while impaired. Gerald Major says such traffic stops are likely to victimize patients using medical cannabis and yet the patients face a bigger impairment threat from the conditions which they are treating rather than the cannabis medication that they consume.

Patients using medical cannabis in Europe also don’t seem to be faring any better. A panelist from Germany and another from the UK revealed that the red tape one must bear in order to get a medical cannabis prescription is extraordinary.

For example, in the UK, specialist doctors must complete a lot of paperwork to the effect that conventional treatment options have been exhausted and the last resort is to try medical marijuana. The requirements make doctors responsible for treating patients with medical marijuana, but doctors are reluctant to prescribe medical marijuana because they don’t have sufficient literature to enable them feel comfortable about prescribing medical cannabis.

In addition to that, the cost of medical marijuana is very high in European where it is legal, and more than a third of all reimbursement claims to insurance companies are rejected for no clear reason. The lack of insurance cover for medical cannabis has put medical marijuana products out of reach for most patients because the cost is prohibitive.

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) agree with the panelists that urgent steps need to be taken to remove all the barriers to access to medical marijuana in all jurisdictions where it is legal.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Las Vegas City Council Votes to Allow Marijuana Lounges

On Wednesday (May 1), the Las Vegas City Council voted 4-1 in favor of a proposed ordinance that would see cannabis consumption lounges licensed to operate within the city. This means that the first consumption lounges could open by the end of this year.

Las Vegas becomes the first city in Nevada to pass regulations allowing cannabis consumption venues to open.

Carolyn Goodman, the mayor of Las Vegas, abstained from voting due to a possible conflict of interest. She had earlier revealed that one of her family members works in the cannabis industry.

According to the ordinance passed, cannabis retailers and dispensaries will be free to apply for a special use license which will allow them to open a cannabis lounge. Once the permit is granted, the licensed business can sell cannabis and allow the buyers to consume marijuana on the premises.

The consumption lounge permit will come with a number of conditions. First, such a lounge should not be located within 1,000 feet from a school or a casino. Additionally, each cannabis lounge must have a system to control smoke so that marijuana smoke doesn’t escape to the exterior of the consumption facility.

Another condition in the ordinance states that no one will be allowed to smoke cannabis outside the consumption lounge. Cannabis lounge operators are also barred from allowing alcohol within the consumption lounge.

The ordinance didn’t pass without some opposition. Casino operators were particularly concerned that licensing cannabis consumption lounges would increase the intoxication issues that casinos have to deal with since someone may use cannabis in a lounge and head to a casino where he or she can consume alcohol.

The restriction of the proximity of cannabis lounges to casinos may have been aimed at addressing the concerns raised by the casino owners, but only time will tell how effective that measure will be.

For now, only businesses with a license to dispense cannabis will be eligible to apply for a marijuana lounge permit. Other interested businesses will have to wait for at least 12 months before they can qualify for the permit.

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) applaud Las Vegas for taking the lead in allowing marijuana lounges in the state of Nevada. This step will solve a longstanding dilemma people have had because they could buy marijuana but didn’t have anywhere they could consume it outside their homes. The economy is therefore likely to benefit now that Las Vegas has decided to allow lounges to open.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Legalization Not Linked to Increased Traffic Fatalities, Study Finds

According to a new study whose findings were released this month, there is no link between the legalization of marijuana and an increase in traffic deaths. This conclusion was arrived at by Andrew Young, a graduate student at Kansas State University after he analyzed traffic deaths data covering 23 years.

Young used two different statistical models to assess how the change in cannabis policy and laws in different states has impacted road safety.

The researcher concluded that the legalization of marijuana isn’t a significant predictor of fatalities on roads. This means that statistically, there is no proof that cannabis legalization leads to either an increase or decrease in the rate of traffic deaths. The data collected was analyzed based on every 100,000 miles traveled on the roads in the states studied.

For the states selected, the data of interest was taken from 5 years before cannabis was legalized either for medical or adult-use, and that data was compared to the data available on road fatalities in those same states after cannabis became legal. Controls (states where cannabis is illegal) were also included in the study. No trends emerged from the data analysis.

For example, the average number of traffic deaths in Arizona weren’t any different from the fatalities recorded in South Dakota and Wyoming where marijuana is illegal.

Similarly, traffic deaths started dropping in Washington just before medical marijuana was legalized, and they kept dropping long after legalization. Interestingly, traffic fatalities in Washington were lower than those in Virginia and Utah where cannabis remains prohibited.

Such concrete observations led the researcher to conclude that the recent rise in the rate of traffic deaths across the U.S. isn’t because marijuana has been legalized in more states in recent years.

The research findings also prove that policy makers who oppose cannabis legalization on the basis that traffic fatalities will increase have no justification to have such fears.

While this study hasn’t yet been published in a peer-reviewed journal, some concerns have been raised about the small sample size of the states where cannabis is legal for recreational use. Can such a small number provide data that is representative of the whole country, they wonder.

Nonetheless, Young’s findings can be regarded as highly credible because they are no different from previous research that hasn’t found any link between marijuana legalization and spikes in road accident fatalities.

SinglePoint, Inc. (OTCQB: SING) and Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) are glad that independent scientific data is coming to light to dispel the myth that legalizing marijuana triggers a rise in traffic deaths.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Another Connecticut Legislative Committee Approves Cannabis Legalization

The Judiciary Committee in Connecticut’s Assembly has also approved a bill that will pave the way for marijuana legalization. This is after the General Law Committee also approved a bill on cannabis legalization.

The move to legalize recreational cannabis in Connecticut is still in its early stages, and the legislators have opted to draft different bills covering different aspects of legalization before merging all those bills into one once they are passed by the relevant committees.

The bill before the Judiciary Committee was hotly contested and it passed with a slim majority (21 votes in favor and 19 against).

If the bill becomes law, adults who are 21 or older would be allowed to possess a maximum of 1.5 ounces of cannabis and a maximum of 5 grams of cannabis concentrates. The bill outlaws the home cultivation of cannabis.

During the meeting of the Judiciary Committee, some members expressed concerns about the possible effects of cannabis legalization on impaired driving and youth consumption. However, many of these individuals acknowledged that voting against the bill would be a futile undertaking since cannabis legalization was inevitable.

The bill eventually passed, and it is now headed to the Finance Committee. Thereafter, the different bills will be combined into one prior to being tabled before the entire legislative assembly for consideration.

Cannabis advocates generally support the bill, although they suggest that it should be improved in several aspects.

One area of improvement suggested by the Marijuana Policy Project has to do with the expungement provisions. The advocates suggest that all prior cannabis convictions should be expunged. They also want the bill to include a provision that allows residents to grow their own recreational marijuana.

Other advocates also want the law to be clear about the way in which the different communities that suffered the brunt of the so-called war on drugs can benefit from the opportunities created in the legal cannabis industry.

As things stand, both sides on this debate may have to make concessions if the bill is to have a chance of becoming a law soon. Otherwise, a lack of consensus and compromise may create a situation similar to what has played out in New York State where adult-use cannabis could not be included in the state budget due to disagreements regarding the way in which the legalization policy would be implemented.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint Inc. (OTCQB: SING) hope that the path to cannabis legalization gets smoother as the different bills leave the different House Committees in Connecticut.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Michigan Commission Advises the State to Avoid Setting THC Impairment Limit for Drivers

The Impaired Driving Safety Commission, a body that was set up by Michigan’s Governor, has recommended that the state should not set any threshold for the THC content in someone’s blood before that person is regarded as being impaired while driving.

This six-member panel was mandated to find a scientifically-backed limit for THC in blood and suggest what provisions should be put in the law to define when a driver is impaired by cannabis.

The members of the commission include a toxicologist, a law enforcement officer, a medical cannabis patient, doctors and cannabis use and traffic experts.

This panel wrote in its report that there was no scientific information upon which they could base a decision on how much THC in someone’s blood renders that person impaired while driving.

Additionally, the commission stated that there wasn’t any correlation between the amount of THC present in a driver’s blood and driving impairment.

The members also observed that according to the research they reviewed, the THC content in someone’s blood drops rapidly shortly after the person consumes cannabis. Conversely, impairment increases slowly and reaches its peak long after THC levels have dropped in that individual’s blood.

The issue of impairment is also affected by someone’s history of cannabis consumption. For example, a non-regular user of cannabis may become impaired after taking a small amount of marijuana.

However, a more regular user may require a larger dose of the substance in order to be impaired to the same degree as the individual who is an irregular user and consumed a little cannabis. Consequently, the commission recommended that the THC level in someone’s blood was a poor determinant of whether that person was driving while impaired.

The panel then suggested that roadside sobriety tests should be used as a more reliable way to determine if a given driver is impaired or not. This suggestion brings to mind the sobriety tests that are administered to drivers who are suspected of driving under the influence of alcohol.

How then can a police officer distinguish between impairment due to alcohol and impairment due to cannabis consumption? A blood test administered once a person fails the sobriety tests can help to distinguish between impairment caused by cannabis and that caused by alcohol.

The findings of this commission bring to question the decision of the states that set a THC threshold to determine when a driver is impaired by cannabis.

For example, Colorado, Montana and Washington State put the threshold at 5ng/ml. Nevada put the limit at 2ng/ml while Pennsylvania set its limit at 1ng/ml. How were these limits arrived at?

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint, Inc. (OTCQB: SING) applaud the commission for looking at the available scientific data and then making an objective decision without being influenced by what other states have done to define driving while impaired by cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Two New Jersey Committees Voted on Marijuana Legalization Today

Two committees in the New Jersey Senate and Assembly voted on a bill to legalize recreational marijuana today (March 18). If the bill passed in both committees, then the entire House could vote on the matter as soon as March 25.

Stephen Sweeney, the Senate President, revealed that the members had received copies of the bill on Thursday last week and that the Democrats in the House have started talking to Republicans in order to get some of them to vote for the bill.

The support of some Republicans was crucial, because a number of prominent Democrats in the House were likely to vote against the bill. In order to pass, at least 21 Senators needed to vote for the bill.

The current bill is a modified form of the original version. The tax system suggested in the original version was changed so that marijuana could be taxed by weight instead of imposing an excise tax on every sale made.

The modified bill also has a provision to expunge the criminal record of individuals who were arrested or convicted for marijuana distribution. This didn’t exist in the previous version of the marijuana legalization bill.

It is this modified bill that the Senate Judiciary committee considered and voted on at 2:00 p.m. today, while the Appropriations Committee of the Assembly sat at noon today.

Marijuana proponents say they aren’t inventing marijuana. Rather, it is present in the different communities, and the social injustices committed during the so-called war on drugs also exist.

Passing the legalization bill would regulate the cannabis industry and get it out of the hands of criminal gangs. The state would earn taxes from the industry and thousands of jobs would be created. All this isn’t bad, the advocates say.

Another bill that was voted on today aims at increasing the quantity of medical cannabis that a patient can buy in the state. The bill also set in motion steps to end the imposition of excise tax on medical cannabis by 2024, in addition to legalizing marijuana edibles.

A third bill aims at making it easier for New Jersey to expunge marijuana charges from the criminal records of those who qualify under the law. For example, the mandatory time that must elapse before the charges are expunged will be reduced under this law.

This week may potentially be a turning point as far as marijuana is concerned in New Jersey. SinglePoint, Inc. (OTCQB: SING) and Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) called for an objective assessment of the bills before voting took place. Such a sober approach will ensure that the best decisions are made on behalf of the people of New Jersey.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Savvy Companies Seizing Opportunities in Growing Cannabis Market

CannabisNewsWire Editorial Coverage: As the cannabis industry expands, companies are eyeing strategic opportunities in the sector designed to help them establish a foothold in the promising space.

  • Cannabis and related products are legal in Canada and an increasing number of states.
  • Businesses have responded with a growing range of diverse products.
  • Companies making the smartest investments, including carefully selected mergers and acquisitions, are in the best position to profit.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) just signed of letter of intent with Malta Enterprises, the economic development agency of Malta. MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) recently wrapped up its previously announced acquisition of Kannaboost Technology Inc. and CSI Solutions LLC, two vertically integrated Arizona-based operations. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) reported more than 10 times growth in harvested hemp compared to its 2017 grow season. And Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) has signed a definitive agreement to acquire…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Smart Investment Leads to Big Opportunities in Growing Cannabis Market

CannabisNewsWire Editorial Coverage: As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space.

  • Cannabis and related products are legal in an ever-increasing number of jurisdictions.
  • Businesses have responded with an increasingly diverse range of products.
  • Companies making the smartest investments, such as carefully selected mergers and acquisitions, are in the best position to profit from this while minimizing risks.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Marijuana Company of America Inc. (OTCQB: MCOA) (MCOA Profile), with its hemp-oriented business, is expecting a surge in profits following the crop’s federal legalization in the United States in December. Medical Marijuana Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, has seen record sales. PotNetwork Holdings Inc. (OTC: POTN) is reaching out to new customers with a CBD-infused slushy machine. And American Premium Water Corp. (OTC: HIPH) is also pushing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.